Fig. 6From: Construction and validation of a cuproptosis-related five-lncRNA signature for predicting prognosis, immune response and drug sensitivity in breast cancerPrognostic value of CRLs signature in TCGA-BrCa cohort. A, B Univariate and multivariate cox regression analyses for the risk score signature; C ROC curves predicted OS of risk characteristics; D,E A nomogram and its calibration to quantify the 1, 3, and 5-year survival probabilitiesBack to article page